Login
$XNCR
$29.21 +$0.03 (0.1%) After hours

Company Executives

$XNCR Management Team

Dr. Bassil Dahiyat

President

Chief Executive Officer

Founder and Director

Age 54
Compensation $6.812M USD
Sex Male

Mr. Bart Cornelissen

Senior Vice President

Chief Financial Officer

Age 47
Compensation $3.731M USD
Sex Male

Dr. John Desjarlais

Executive Vice President - Research

Chief Scientific Officer

Age 60
Compensation $2.828M USD
Sex Male

Ms. Celia Eckert

Senior Vice President

General Counsel

Corporate Secretary

Age 53
Compensation $1.972M USD
Sex Female
Directors
9
serving now
Independent
7 of 7
stated in the proxy; 2 not stated
Average tenure
9.2 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Bassil I. Dahiyat
55 1997
29 years
Not stated None stated Kodiak Sciences Inc. Paid as CEO
Raymond J. Deshaies
64 2025
1 year
Independent None stated None stated $537,938
Ellen G. Feigal
71 2018
8 years
Independent None stated NextCure, Inc., Prescient Therapeutics Limited $342,240
Kevin C. Gorman
68 2017
9 years
Independent None stated Neurocrine Biosciences, Inc. $336,740
Kurt A. Gustafson
58 2014
12 years
Not stated None stated None stated $340,740
Barbara J. Klencke
68 2023
3 years
Independent
Nominating and Corporate Governance Committee · Chair
TScan Therapeutics, Inc. $337,990
A. Bruce Montgomery
72 2015
11 years
Independent None stated None stated $376,740
Richard J. Ranieri
74 2017
9 years
Independent None stated None stated $344,240
Todd E. Simpson
65 2025
1 year
Independent None stated None stated $624,795

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 27, 2026
Directors and executive officers
directors and executive officers of the Company
Amount not stated

Indemnification agreements requiring the Company to indemnify directors and executive officers for certain expenses, judgments, fines and settlement amounts arising from their services.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support